In the original article published, the last sentence in the sixth paragraph of the introduction section is incorrect. The correct sentence is “This data, were confirmed also in an Italian phase II study, in which it has been demonstrated that gemcitabine-based chemoradiotherapy was correlated with improved overall survival, especially in pts who are clinically more fit to complete the foreseen treatment schedule (CRT) (Mattiucci et al. 2010)”. The original article has been corrected.
Mattiucci, G. C., Boldrini, L., Nardangeli, A., D'Aviero, A., Buwenge, M., Cellini, F., Deodato, F., Dinapoli, N., Frascino, V., Macchia, G., Morganti, A. G., Valentini, V., Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7), <<JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY>>, 2021; 147 (3): 669-669. [doi:10.1007/s00432-020-03439-9] [http://hdl.handle.net/10807/203401]
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7)
Mattiucci, G. C.;Boldrini, L.;Cellini, F.;Deodato, F.;Dinapoli, N.;Frascino, V.;Macchia, G.;Morganti, A. G.;Valentini, V.
2021
Abstract
In the original article published, the last sentence in the sixth paragraph of the introduction section is incorrect. The correct sentence is “This data, were confirmed also in an Italian phase II study, in which it has been demonstrated that gemcitabine-based chemoradiotherapy was correlated with improved overall survival, especially in pts who are clinically more fit to complete the foreseen treatment schedule (CRT) (Mattiucci et al. 2010)”. The original article has been corrected.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
